RedHill Biopharma Schedules Annual General Meeting for May 5
Ticker: RDHL · Form: 6-K · Filed: Mar 26, 2025 · CIK: 1553846
| Field | Detail |
|---|---|
| Company | Redhill Biopharma Ltd. (RDHL) |
| Form Type | 6-K |
| Filed Date | Mar 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
Related Tickers: RHBP
TL;DR
RHBP set its AGM for May 5th - shareholder votes coming up.
AI Summary
RedHill Biopharma Ltd. has filed a Form 6-K on March 26, 2025, to report the notice of its annual general meeting of shareholders. The meeting is scheduled to take place on May 5, 2025. This filing is incorporated by reference into several of the company's previous S-8 registration statements.
Why It Matters
The annual general meeting is a key event for shareholders to vote on important company matters and for the company to communicate its strategic direction.
Risk Assessment
Risk Level: low — This filing is a routine notification of a shareholder meeting and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- RedHill Biopharma Ltd. (company) — Registrant
- May 5, 2025 (date) — Annual General Meeting Date
- March 26, 2025 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K filing serves to report the notice of the annual general meeting of RedHill Biopharma Ltd. shareholders.
When is the annual general meeting scheduled to take place?
The annual general meeting is scheduled for May 5, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at 21 Ha'arba'a Street, Tel Aviv, 6473921, Israel.
Does RedHill Biopharma file annual reports under Form 20-F or 40-F?
RedHill Biopharma indicates it files annual reports under Form 20-F.
What is the Commission File Number for RedHill Biopharma?
The Commission File Number for RedHill Biopharma Ltd. is 001-35773.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 26, 2025 regarding RedHill Biopharma Ltd. (RDHL).